EDGAR Filing Documents for 0001493152-22-018686

Form 8-K - Current report:

SEC Accession No. 0001493152-22-018686

Filing Date

2022-07-06

Accepted

2022-07-06 16:15:38

Documents

Period of Report

2022-07-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	61519
2		ex4-6.htm	EX-4.6	210648
3		ex4-7.htm	EX-4.7	121599
4		ex10-1.htm	EX-10.1	353851
5		ex10-2.htm	EX-10.2	174750
6		ex10-3.htm	EX-10.3	105940
7		ex10-4.htm	EX-10.4	224339
8		ex10-5.htm	EX-10.5	1188292
9		ex99-1.htm	EX-99.1	15807
	Complete submission text file	0001493152-22-018686.txt		2964848

Data Files

Seq	Description	Document	Type	Size
10	XBRL SCHEMA FILE	ensc-20220706.xsd	EX-101.SCH	3704
11	XBRL DEFINITION FILE	ensc-20220706_def.xml	EX-101.DEF	26619
12	XBRL LABEL FILE	ensc-20220706_lab.xml	EX-101.LAB	36693
13	XBRL PRESENTATION FILE	ensc-20220706_pre.xml	EX-101.PRE	25243
15	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	5430

Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037

Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196

Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)